Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer
PHASE3
To compare the efficacy and safety of PERT-IJS (Proposed biosimilar Pertuzu...
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
PHASE2
This phase II trial studies the immunologic response and side effects of us...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium